J Med Genet. Published Online First: 14 September 2007. doi:10.1136/jmg.2007.052670
Original articles |
Genotype-phenotype study of familial hemophagocytic lymphohistiocytosis due to perforin mutations
1 Pediatric Hematology Oncology, Ospedale dei Bambini "G. Di Cristina", ARNAS Civico, Pale, Italy
2 Department of Pediatric Hematology Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
3 Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan
4 Cincinnati Children's Hospital Medical Center, OH, United States
5 Department of Pediatrics, Ehime University Graduate School of Medicine, Ehime, Japan
6 Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
7 Arkansas Children Hospital, Arkansa, United States
8 Childhood Cancer Research Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
9 Sir William Dunn School of Pathology, Oxford, United Kingdom
10 Ematologia I, A.O. Cervello & Pediatric Hematology Oncology, Ospedale dei Bambini "G. Di Crist, Italy
11 Ospedale dei Bambini G. Di Cristina, Palermo, Italy
* To whom correspondence should be addressed. E-mail: arico{at}ospedalecivicopa.org.
Accepted 19 August 2007
Abstract
Background: PRF1 gene mutations are associated with familial hemophagocytic lymphohistiocytosis type 2 (FHL2). Genotype-phenotype analysis, previously hampered by limited number of patients, was performed for the first time by data pooling from 5 large centers worldwide.
Patients and methods: Members of the Histiocyte Society were asked to report cases of FHL2 on specific forms. Data were pooled in a common data-based and analysed.
Results: The 124 patients had 63 different mutations, including 15 novel: 11 nonsense, 10 frameshift, 38 missense, 4 in-frame deletions. Some mutations were found more frequently: 1122 G>A (W374X), associated with Turkish origin, in 32 patients; 50delT (L17fsX22) associated with Afro(American) origin, in 21; 1090-91delCT (L364fsX), in 7 Japanese patients.
Perforin expression was absent at flow-cytometry in 40, reduced in 6, normal in 4 patients.
Patients presented at a median age of 3 months (quartiles: 2, 3, and 13 months), always with fever, splenomegaly, and thrombocytopenia. NK activity was absent in 36 (51%),
2% in 18 (26%), 3 to
5% in 10 (14%), >5% in 4 (6%), "reduced" in 2 (3%) (not reported, n=54). Nonsense mutations were significantly associated with younger age at onset (p<0.001) and absent NK activity (p=0.008).
Conclusion: PRF1 mutations are spread over the functional domains. Specific mutations are tightly associated with Turkish, Afro-American, and Japanese ethnic groups. Later onset and residual cytotoxic function are observed in patients with at least one missense mutation.
Keywords: Lymphohistiocytosis, Natural killer, Perforin
This article has been cited by other articles:
-
Urrea Moreno, R., Gil, J., Rodriguez-Sainz, C., Cela, E., LaFay, V., Oloizia, B., Herr, A. B., Sumegi, J., Jordan, M. B., Risma, K. A.
(2009). Functional assessment of perforin C2 domain mutations illustrates the critical role for calcium-dependent lipid binding in perforin cytotoxic function. Blood
113: 338-346
[Abstract] [Full Text] -
Santoro, A., Cannella, S., Trizzino, A., Bruno, G., De Fusco, C., Notarangelo, L. D., Pende, D., Griffiths, G. M., Arico, M.
(2008). Mutations affecting mRNA splicing are the most common molecular defect in patients with familial hemophagocytic lymphohistiocytosis type 3. haematol
93: 1086-1090
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
